Cargando…
Vascular Thrombosis and Anti-PD-1 Therapy: A Series of Cases
Immune checkpoint inhibitors may cause unique immune-related adverse events. Vascular thrombosis, especially arterial thrombosis, is rare but life-threatening, and little is known about its relevance to immunotherapy. Here, we reported two cases of vascular thrombosis, including venous and arterial...
Autores principales: | Fu, Changfang, Wang, Gang, Yang, Wulin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629915/ https://www.ncbi.nlm.nih.gov/pubmed/34858058 http://dx.doi.org/10.2147/CMAR.S338023 |
Ejemplares similares
-
The Effect and Safety of Anti-PD-1 Single/Combination Therapy in Refractory Thymic Carcinoma: A Case-Series Study
por: Jin, Wei, et al.
Publicado: (2020) -
An Exploration of Anti-Inflammatory Therapy in Acute/Subacute Severe Cerebral Venous Thrombosis with Hereditary Protein C/S Deficiency: Case Series
por: Hao, Wensi, et al.
Publicado: (2023) -
Dual mechanical valve thrombosis resolution through thrombolytics: a case series
por: McGuire, Colin, et al.
Publicado: (2023) -
Novel oral anticoagulants in intracardiac thrombosis resolution: a case series
por: Al-Sadawi, Mohammed, et al.
Publicado: (2020) -
Large vessel thrombosis in patient with COVID-19, a case series
por: Baram, Aram, et al.
Publicado: (2020)